South Korea approves nationwide compensation system for humidifier disinfectant victims

South Korea’s National Assembly on March 12 approved the full revision of the Special Act on Relief for Victims of Humidifier Disinfectants, transitioning the relief program to a national compensation system. The move was accompanied by a joint statement from six major health and environmental academic societies urging proactive follow-up measures to ensure victims receive proper restitution and long-term protections.

The amended law aims to convert the relief mechanism from a targeted statute into a nationwide entitlement, with implementation details to be set by later regulations. Government officials said the changes are intended to create a more comprehensive, government-led framework to shield citizens from environmental health hazards linked to consumer products.

In their statement, the six associations -- including the Korean Society of Preventive Medicine and the Korean Society of Occupational and Environmental Medicine, along with the Korean Epidemiology Society and several environmental health and toxicology groups -- argued that health impacts from humidifier disinfectants go beyond acute respiratory illness. They urged revising the six-month filing window and recognizing the potential for long-latency, chronic, and multi-system diseases, citing the historical precedent of compensation for late-identified harms from the 1950s thalidomide case.

They also highlighted that humidifier disinfectants were first developed and launched worldwide in 1994, with about 50 products and 10 million units sold by 2011, and that reports of harm have continued since the 2011 disclosure. The associations warned that relying on limited evidence or early settlements could foreclose future claims for newly identified conditions.

The Ministry of Climate, Energy and Environment said the reform will allow a broad review of health damages, extending beyond respiratory illnesses to include eyes, ears, skin, circulatory and digestive disorders, as well as depression. It plans to expand causal-relation research at institutions such as the National Academy of Sciences and medical schools to cover chronic diseases, comorbidities, and sequelae.

Officials noted that when new causal links are established, supplementary provisions will enable affected individuals to pursue compensation and that the statute of limitations for civil damages will reset for those new diseases. While acknowledging concerns about the six-month filing window, they said the framework follows precedents set by similar laws, such as those addressing the Sewol ferry disaster, to safeguard the right to compensation, with grace provisions for those who are temporarily unable to file due to special circumstances like overseas residence.

The government also pledged to establish reasonable standards for compensation, extend long-term health monitoring for affected populations beyond immediate victims and exposure reporters, and keep channels open for ongoing information sharing among experts and stakeholders. It said a compensation-review body would include professionals in public health, epidemiology, and toxicology, and that corporate accountability would be strengthened through enhanced penalties and social responsibility measures.

For U.S. readers, this development matters beyond Korea as it illustrates a growing approach to environmental health harms: formalizing government-backed compensation, expanding recognition of long-latency conditions, and embedding long-term monitoring and expert oversight into remediation efforts. It also signals how product safety crises can drive cross-border policy lessons for regulatory design, corporate accountability, and the governance of complex health risks in a highly interconnected economy.

Subscribe to Journal of Korea

Don’t miss out on the latest issues. Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe